Samantha Kingdom, general manager of Amgen Poland, highlights her strategy to be a significant contributor within the Polish healthcare space, while delivering highly innovative products to significantly improve Polish patients’ lives. Furthermore, she highlights the strong commitment of Amgen Poland to remain at the forefront of the clinical trials landscape, the critical importance of the affiliate within the global operations, and the steps required for Poland to reach its full potential in terms of R&D and innovation.
Thus far, what have been the main challenges you have encountered during your time in Poland?
"We see a very positive future in R&D and biotechnology for Poland, and the current government has put forward a highly ambitious plan to grow these sectors."
